213 related articles for article (PubMed ID: 17620942)
1. Molecular MR imaging of human thrombi in a swine model of pulmonary embolism using a fibrin-specific contrast agent.
Spuentrup E; Katoh M; Buecker A; Fausten B; Wiethoff AJ; Wildberger JE; Haage P; Parsons EC; Botnar RM; Graham PB; Vettelschoss M; Günther RW
Invest Radiol; 2007 Aug; 42(8):586-95. PubMed ID: 17620942
[TBL] [Abstract][Full Text] [Related]
2. Molecular coronary MR imaging of human thrombi using EP-2104R, a fibrin-targeted contrast agent: experimental study in a swine model.
Spuentrup E; Katoh M; Wiethoff AJ; Buecker A; Botnar RM; Parsons EC; Guenther RW
Rofo; 2007 Nov; 179(11):1166-73. PubMed ID: 17948194
[TBL] [Abstract][Full Text] [Related]
3. Molecular magnetic resonance imaging of pulmonary emboli with a fibrin-specific contrast agent.
Spuentrup E; Katoh M; Wiethoff AJ; Parsons EC; Botnar RM; Mahnken AH; Günther RW; Buecker A
Am J Respir Crit Care Med; 2005 Aug; 172(4):494-500. PubMed ID: 15937292
[TBL] [Abstract][Full Text] [Related]
4. Molecular magnetic resonance imaging of atrial clots in a swine model.
Spuentrup E; Fausten B; Kinzel S; Wiethoff AJ; Botnar RM; Graham PB; Haller S; Katoh M; Parsons EC; Manning WJ; Busch T; Günther RW; Buecker A
Circulation; 2005 Jul; 112(3):396-9. PubMed ID: 16009790
[TBL] [Abstract][Full Text] [Related]
5. In vivo magnetic resonance imaging of coronary thrombosis using a fibrin-binding molecular magnetic resonance contrast agent.
Botnar RM; Buecker A; Wiethoff AJ; Parsons EC; Katoh M; Katsimaglis G; Weisskoff RM; Lauffer RB; Graham PB; Gunther RW; Manning WJ; Spuentrup E
Circulation; 2004 Sep; 110(11):1463-6. PubMed ID: 15238457
[TBL] [Abstract][Full Text] [Related]
6. Molecular magnetic resonance imaging of coronary thrombosis and pulmonary emboli with a novel fibrin-targeted contrast agent.
Spuentrup E; Buecker A; Katoh M; Wiethoff AJ; Parsons EC; Botnar RM; Weisskoff RM; Graham PB; Manning WJ; Günther RW
Circulation; 2005 Mar; 111(11):1377-82. PubMed ID: 15738354
[TBL] [Abstract][Full Text] [Related]
7. Thrombus imaging with fibrin-specific gadolinium-based MR contrast agent EP-2104R: results of a phase II clinical study of feasibility.
Vymazal J; Spuentrup E; Cardenas-Molina G; Wiethoff AJ; Hartmann MG; Caravan P; Parsons EC
Invest Radiol; 2009 Nov; 44(11):697-704. PubMed ID: 19809344
[TBL] [Abstract][Full Text] [Related]
8. Molecular magnetic resonance imaging of deep vein thrombosis using a fibrin-targeted contrast agent: a feasibility study.
Katoh M; Haage P; Wiethoff AJ; Günther RW; Bücker A; Tacke J; Spuentrup E
Invest Radiol; 2009 Mar; 44(3):146-50. PubMed ID: 19151606
[TBL] [Abstract][Full Text] [Related]
9. Molecular magnetic resonance imaging of myocardial perfusion with EP-3600, a collagen-specific contrast agent: initial feasibility study in a swine model.
Spuentrup E; Ruhl KM; Botnar RM; Wiethoff AJ; Buhl A; Jacques V; Greenfield MT; Krombach GA; Günther RW; Vangel MG; Caravan P
Circulation; 2009 Apr; 119(13):1768-75. PubMed ID: 19307474
[TBL] [Abstract][Full Text] [Related]
10. Chronic thrombus detection with in vivo magnetic resonance imaging and a fibrin-targeted contrast agent.
Sirol M; Fuster V; Badimon JJ; Fallon JT; Moreno PR; Toussaint JF; Fayad ZA
Circulation; 2005 Sep; 112(11):1594-600. PubMed ID: 16145001
[TBL] [Abstract][Full Text] [Related]
11. EP-2104R: a fibrin-specific gadolinium-Based MRI contrast agent for detection of thrombus.
Overoye-Chan K; Koerner S; Looby RJ; Kolodziej AF; Zech SG; Deng Q; Chasse JM; McMurry TJ; Caravan P
J Am Chem Soc; 2008 May; 130(18):6025-39. PubMed ID: 18393503
[TBL] [Abstract][Full Text] [Related]
12. Molecular MRI of cerebral venous sinus thrombosis using a new fibrin-specific MR contrast agent.
Stracke CP; Katoh M; Wiethoff AJ; Parsons EC; Spangenberg P; Spüntrup E
Stroke; 2007 May; 38(5):1476-81. PubMed ID: 17379818
[TBL] [Abstract][Full Text] [Related]
13. Gadocoletic acid trisodium salt (b22956/1): a new blood pool magnetic resonance contrast agent with application in coronary angiography.
de Haën C; Anelli PL; Lorusso V; Morisetti A; Maggioni F; Zheng J; Uggeri F; Cavagna FM
Invest Radiol; 2006 Mar; 41(3):279-91. PubMed ID: 16481911
[TBL] [Abstract][Full Text] [Related]
14. MR imaging of thrombi using EP-2104R, a fibrin-specific contrast agent: initial results in patients.
Spuentrup E; Botnar RM; Wiethoff AJ; Ibrahim T; Kelle S; Katoh M; Ozgun M; Nagel E; Vymazal J; Graham PB; Günther RW; Maintz D
Eur Radiol; 2008 Sep; 18(9):1995-2005. PubMed ID: 18425519
[TBL] [Abstract][Full Text] [Related]
15. Brain tumor enhancement in magnetic resonance imaging at 3 tesla: intraindividual comparison of two high relaxivity macromolecular contrast media with a standard extracellular gd-chelate in a rat brain tumor model.
Fries P; Runge VM; Bücker A; Schürholz H; Reith W; Robert P; Jackson C; Lanz T; Schneider G
Invest Radiol; 2009 Apr; 44(4):200-6. PubMed ID: 19300099
[TBL] [Abstract][Full Text] [Related]
16. Magnetic resonance coronary angiography: comparison between a Gd-BOPTA- and a Gd-DTPA-enhanced spoiled gradient-echo sequence and a non-contrast-enhanced steady-state free-precession sequence.
Nassenstein K; Breuckmann F; Hunold P; Barkhausen J; Schlosser T
Acta Radiol; 2009 May; 50(4):406-11. PubMed ID: 19308763
[TBL] [Abstract][Full Text] [Related]
17. High spatial resolution magnetic resonance imaging of experimental cerebral venous thrombosis with a blood pool contrast agent.
Spuentrup E; Wiethoff AJ; Parsons EC; Spangenberg P; Stracke CP
Eur J Radiol; 2010 Jun; 74(3):445-52. PubMed ID: 19394183
[TBL] [Abstract][Full Text] [Related]
18. Monovalent and bivalent fibrin-specific MRI contrast agents for detection of thrombus.
Nair SA; Kolodziej AF; Bhole G; Greenfield MT; McMurry TJ; Caravan P
Angew Chem Int Ed Engl; 2008; 47(26):4918-21. PubMed ID: 18496805
[No Abstract] [Full Text] [Related]
19. A new class of Gd-based DO3A-ethylamine-derived targeted contrast agents for MR and optical imaging.
Mishra A; Pfeuffer J; Mishra R; Engelmann J; Mishra AK; Ugurbil K; Logothetis NK
Bioconjug Chem; 2006; 17(3):773-80. PubMed ID: 16704217
[TBL] [Abstract][Full Text] [Related]
20. Fibrin-targeted contrast agent for improvement of in vivo acute thrombus detection with magnetic resonance imaging.
Sirol M; Aguinaldo JG; Graham PB; Weisskoff R; Lauffer R; Mizsei G; Chereshnev I; Fallon JT; Reis E; Fuster V; Toussaint JF; Fayad ZA
Atherosclerosis; 2005 Sep; 182(1):79-85. PubMed ID: 16115477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]